SCHEMBL6432275

SCHEMBL6432275

CC(=C(C(N)=O)c1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.50
CYP2C19 P33261 2/20 0.50
POLB P06746 1/20 0.50
CYP3A4 P08684 1/20 0.50
PARP1 P09874 1/20 0.50
MAPT P10636 1/20 0.50
RECQL P46063 1/20 0.50
BLM P54132 1/20 0.50
PMP22 Q01453 1/20 0.50
HSD17B10 Q99714 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
CES2 O00748 3/20 0.46
CES1 P23141 3/20 0.46
PTGS1 P23219 1/20 0.46
GAA P10253 1/20 0.45
ALDH1A1 P00352 3/20 0.44
LMNA P02545 1/20 0.44
DAO P14920 1/20 0.42
NAPRT Q6XQN6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28353839 0.84 TSHR (0.52) TSHRCYP2C19POLBCYP3A4PARP1
SCHEMBL20610672 0.84 TSHR (0.52) TSHRCYP2C19POLBCYP3A4PARP1
SCHEMBL10497226 0.84 TDP1 (0.62) TSHRCYP2C19POLBCYP3A4PARP1
SCHEMBL1415252 0.84 TDP1 (0.62) TSHRCYP2C19POLBCYP3A4PARP1
SCHEMBL7567511 0.84 TDP1 (0.62) TSHRCYP2C19POLBCYP3A4PARP1
SCHEMBL14677026 0.83 TSHR (0.50) TSHRCYP2C19POLBCYP3A4PARP1
SCHEMBL14677020 0.83 TSHR (0.50) TSHRCYP2C19POLBCYP3A4PARP1
SCHEMBL13731489 0.82 F7 (0.56) CYP3A4TDP1GAAALDH1A1LMNA
SCHEMBL13731493 0.82 F7 (0.56) CYP3A4TDP1GAAALDH1A1LMNA
SCHEMBL4744665 0.82 TSHR (0.54) TSHRCYP2C19POLBCYP3A4PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1556032-A1 AGENT FOR PREVENTING OR TREATING NEUROPATHY Takeda Pharmaceutical Company Limited (JP) 2005-07-27 EP disclosed
WO-2004039365-A1 AGENT FOR PREVENTING OR TREATING NEUROPATHY TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-05-13 WO disclosed